Investor Type | Firm |
Industries | Businesses Solutions • FinTech (& Financials services) • Logistics (& Distribution) • Pharmaceutical (& Medicine) |
Stages | Seed Round, Early Stage VC, Series A |
Investing | United Kingdom • Germany • Greece |
Investment Range | $100,000 - $5,000,000 |
Investment Sweet Spot | $1,500,000 |
Yarrow Capital is an investment fund headquartered in Berg Kaprow Lewis Llp, 35 Ballards Lane, London N3 1XW, England, United Kingdom. The firm specializes in providing capital to early-stage companies, focusing on Seed Round, Early Stage VC, and Series A funding stages.
They support entrepreneurs and unique talent aiming to build disruptive technologies and high growth businesses in various industries including Business Solutions, FinTech (& Financial Services), Logistics (& Distribution), and Pharmaceutical (& Medicine). Yarrow Capital has a broad investment range, typically investing between £100,000 and £5,000,000, with a sweet spot of around £1,500,000. Their investment approach combines financial support with strategic guidance to help portfolio companies scale effectively.
Notable investments include Oseven, Sybenetix, and Loyalty Lion, each representing their commitment to innovation across different sectors. Oseven specializes in insurance telematics and behavioral analytics, which aims to transform the motor insurance market with its user-centric platform.
Sybenetix, acquired by Nasdaq, exemplifies the fund's success in backing companies with significant growth potential, bringing behavioral analytics and cognitive computing to financial markets.
Loyalty Lion redefines loyalty programs for e-commerce, moving past traditional models to offer a more engaging customer retention framework.
Yarrow Capital also has interest in cutting-edge solutions like AMFG's automation of industrial additive manufacturing workflows, Starship's advanced delivery robots, Albert's invoicing and expense tools, Pixel Reign's game development endeavors, and Tymit's app-enabled credit card.
Other innovative ventures in their portfolio include Noma, which caters to pet nutrition, Setyl's efficient management of technology spend for businesses, Attralus's work in systemic amyloidosis therapeutics, and i-Flow's data integration services for manufacturing.
Through their varied investments, Yarrow Capital is carving out a space as a forward-thinking, strategic investor with an eye for industry-transforming technologies and business models.